The Utility of Antiplatelet Assay-Guided Individualized Dual Antiplatelet Therapy in Carotid Artery Stenting for Unstable Plaques
Journal of Korean Neurosurgical Society · 01.05.2026 · 69 (3) · 433-440
DOI: 10.3340/jkns.2025.0170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Korean Neurosurgical Society, erschienen am 01.05.2026. Verfasst von Sujong Pak und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Yokosuka General Medical Center, Yokosuka, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Objective
To evaluate the efficacy of individualized dual antiplatelet therapy (DAPT) using VerifyNow in reducing periprocedural ischemic complications following carotid artery stenting (CAS), particularly in patients with unstable plaques.
Methods
This retrospective, single-center study included 187 patients who underwent elective CAS between January 2018 and September 2024. Patients were divided into two groups : a conventional DAPT (c-DAPT) group treated with aspirin and clopidogrel (n=89), and an individualized DAPT (i-DAPT) group (n=98) where antiplatelet regimens were adjusted based on preoperative platelet reactivity measured by VerifyNow. The primary outcome was the incidence of ischemic lesions on diffusion-weighted imaging (DWI) following CAS. Risk factors and the impact of DAPT personalization on ischemic changes were analyzed using multivariate logistic regression.
Results
DWI-positive ischemic lesions were observed in 62.9% of the c-DAPT group and 51% of the i-DAPT group (p=0.07). Although the difference was not statistically significant, there was a trend toward reduced ischemic changes with individualized therapy. Multivariate analysis identified hypertension, diabetes mellitus, and unstable plaque as independent predictors of post-CAS ischemic changes. Subgroup analysis showed that VerifyNow-guided i-DAPT significantly reduced ischemic events in patients with unstable plaques (odds ratio, 0.49; p=0.03), whereas no significant effect was observed in other subgroups.
Conclusion
VerifyNow-guided personalization of antiplatelet therapy is a safe and may have the potential to reduce periprocedural ischemic complications in CAS, particularly in patients with unstable plaques. Further multicenter prospective studies are needed to validate these findings and optimize individualized antiplatelet regimens.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Yokosuka General Medical Center, Yokosuka, Japan.
- Department of Neuroendovascular Surgery, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.
- Department of Neurosurgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
- Department of Neurosurgery, Minato Red Cross Hospital, Yokohama, Japan.
- Department of Neurosurgery, Hiratsuka Kyosai Hospital, Hiratsuka, Japan.
- Department of Neurosurgery, Wakayama Rosai Hospital, Wakayama, Japan.
Zitieren
APA
Pak, S., Miyake, S., Masuo, O., Takase, K., Tetsuo, Y., Shimohigoshi, W., Umesaki, A., Akimoto, T., Nakai, Y., & Yamamoto, T. (2026). The Utility of Antiplatelet Assay-Guided Individualized Dual Antiplatelet Therapy in Carotid Artery Stenting for Unstable Plaques. Journal of Korean Neurosurgical Society, 69(3), 433-440. https://doi.org/10.3340/jkns.2025.0170
Vancouver
Pak S, Miyake S, Masuo O, Takase K, Tetsuo Y, Shimohigoshi W, et al. The Utility of Antiplatelet Assay-Guided Individualized Dual Antiplatelet Therapy in Carotid Artery Stenting for Unstable Plaques. Journal of Korean Neurosurgical Society. 2026;69(3):433-440. doi:10.3340/jkns.2025.0170
BibTeX
@article{Pak2026,
author = {Pak, Sujong and Miyake, Shigeta and Masuo, Osamu and Takase, Kana and Tetsuo, Yoshiaki and Shimohigoshi, Wataru and Umesaki, Arisa and Akimoto, Taisuke and Nakai, Yasunobu and Yamamoto, Tetsuya},
title = {The Utility of Antiplatelet Assay-Guided Individualized Dual Antiplatelet Therapy in Carotid Artery Stenting for Unstable Plaques},
journal = {Journal of Korean Neurosurgical Society},
year = {2026},
volume = {69},
number = {3},
pages = {433--440},
doi = {10.3340/jkns.2025.0170}
}
EUVIMED